ERIN HODGES: Open Payments
NPI 1942988431 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,492 in 113 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,532 · 2025 $2,492
Food & beverage: $2,492
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $392 |
| AstraZeneca Pharmaceuticals LP | 6 | $294 |
| Medtronic, Inc. | 3 | $247 |
| Inspire Medical Systems, Inc. | 2 | $236 |
| Amgen Inc. | 22 | $235 |
| Merck Sharp & Dohme LLC | 11 | $225 |
| Alnylam Pharmaceuticals Inc. | 11 | $191 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $171 |
| Novo Nordisk Inc | 5 | $85 |
| E.R. Squibb & Sons, L.L.C. | 5 | $84 |
Products named: LEQVIO, INSPIRE, REPATHA, VERQUVO, AMVUTTRA, Kerendia, FARXIGA, AURORA EV-ICD MRI SURESCAN.
Industry payments across MS — which companies pay providers there.
